K-numberK253925
Device nameAventus Thrombectomy System
ApplicantInquis Medical
Product codeQEZ
Device classClass II
Decision dateJan 15, 2026
DecisionSubstantially Equivalent
Regulation870.5150
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Aventus Thrombectomy System is a catheter-based manual aspiration device designed for minimally invasive removal of blood clots (emboli and thrombi) from blood vessels, particularly in the peripheral vasculature and pulmonary arteries. It also enables injection, infusion, and aspiration of contrast media and other fluids. The system comprises an aspiration catheter with an atraumatic tip and embedded sensors, plus a 60-cc manual syringe and clot canister.

Technological characteristics

Both the subject and predicate devices are single-patient-use, large-bore aspiration catheters utilizing a 60-cc manual syringe for aspiration. They share metallic (stainless steel) reinforced polymeric shafts with variable stiffness, radiopaque distal-tip markings for fluoroscopy, disposable powered electronics with embedded software, and stopcocks for fluid flow direction. The key modification is the addition of a hydrophilic coating to the outer catheter shaft of the subject device.

Test standards cited

ISO 10993-1:2018 (biocompatibility), ISO 14937:2009 (sterilization validation), USP <85> and AAMI ST72 (bacterial endotoxin testing), IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, and IEC 62366-1 (electrical safety and EMC), plus FDA guidance on animal studies and software content for medical devices.

Substantial equivalence argument

The Aventus Thrombectomy System is substantially equivalent to its predicate device (K251189) because both share identical intended uses, indications for use, and core technological characteristics as single-patient-use aspiration catheters with manual syringe actuation. Performance testing—including biocompatibility, sterilization, bench testing for coating integrity, animal studies, and clinical data from the AVENTUS trial—demonstrates safety and effectiveness equivalent to the predicate, with the minor modification of hydrophilic coating not affecting the fundamental function or safety profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →